Logo image of DOX.MI

DOXEE SPA (DOX.MI) Stock Fundamental Analysis

BIT:DOX - Euronext Milan - IT0005394413 - Common Stock - Currency: EUR

1.54  -0.01 (-0.96%)

Fundamental Rating

2

Taking everything into account, DOX scores 2 out of 10 in our fundamental rating. DOX was compared to 97 industry peers in the Software industry. Both the profitability and financial health of DOX have multiple concerns. While showing a medium growth rate, DOX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DOX has reported negative net income.
DOX had a positive operating cash flow in the past year.
DOX had positive earnings in 4 of the past 5 years.
In the past 5 years DOX always reported a positive cash flow from operatings.
DOX.MI Yearly Net Income VS EBIT VS OCF VS FCFDOX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

DOX has a Return On Assets of -9.66%. This is in the lower half of the industry: DOX underperforms 72.16% of its industry peers.
DOX has a Return On Equity of -42.86%. This is in the lower half of the industry: DOX underperforms 76.29% of its industry peers.
Industry RankSector Rank
ROA -9.66%
ROE -42.86%
ROIC N/A
ROA(3y)-1.48%
ROA(5y)1.53%
ROE(3y)-19.24%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
DOX.MI Yearly ROA, ROE, ROICDOX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 2K 4K 6K

1.3 Margins

With a Gross Margin value of 61.63%, DOX perfoms like the industry average, outperforming 44.33% of the companies in the same industry.
DOX's Gross Margin has declined in the last couple of years.
DOX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-7.14%
DOX.MI Yearly Profit, Operating, Gross MarginsDOX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

DOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DOX has less shares outstanding than it did 1 year ago.
DOX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOX is higher compared to a year ago.
DOX.MI Yearly Shares OutstandingDOX.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
DOX.MI Yearly Total Debt VS Total AssetsDOX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.26, we must say that DOX is in the distress zone and has some risk of bankruptcy.
DOX's Altman-Z score of 0.26 is on the low side compared to the rest of the industry. DOX is outperformed by 78.35% of its industry peers.
A Debt/Equity ratio of 1.31 is on the high side and indicates that DOX has dependencies on debt financing.
With a Debt to Equity ratio value of 1.31, DOX is not doing good in the industry: 80.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACC9.01%
DOX.MI Yearly LT Debt VS Equity VS FCFDOX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

DOX has a Current Ratio of 0.66. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.66, DOX is doing worse than 82.47% of the companies in the same industry.
DOX has a Quick Ratio of 0.66. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
DOX has a Quick ratio of 0.66. This is amonst the worse of the industry: DOX underperforms 82.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
DOX.MI Yearly Current Assets VS Current LiabilitesDOX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

DOX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.07%.
Looking at the last year, DOX shows a small growth in Revenue. The Revenue has grown by 5.33% in the last year.
DOX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.47% yearly.
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44%
Revenue 1Y (TTM)5.33%
Revenue growth 3Y13.43%
Revenue growth 5Y13.47%
Sales Q2Q%3.22%

3.2 Future

Based on estimates for the next years, DOX will show a very strong growth in Earnings Per Share. The EPS will grow by 34.84% on average per year.
DOX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.10% yearly.
EPS Next Y30.2%
EPS Next 2Y42.87%
EPS Next 3Y34.84%
EPS Next 5YN/A
Revenue Next Year18.71%
Revenue Next 2Y14.6%
Revenue Next 3Y13.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DOX.MI Yearly Revenue VS EstimatesDOX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DOX.MI Yearly EPS VS EstimatesDOX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 76.24, the valuation of DOX can be described as expensive.
DOX's Price/Forward Earnings ratio is in line with the industry average.
DOX is valuated expensively when we compare the Price/Forward Earnings ratio to 20.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 76.24
DOX.MI Price Earnings VS Forward Price EarningsDOX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DOX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.44
DOX.MI Per share dataDOX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DOX's earnings are expected to grow with 34.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.87%
EPS Next 3Y34.84%

More info and screens

0

5. Dividend

5.1 Amount

DOX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOXEE SPA

BIT:DOX (5/5/2025, 7:00:00 PM)

1.54

-0.01 (-0.96%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.69M
Analysts80
Price Target6.86 (345.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-322.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 76.24
P/S 0.67
P/FCF N/A
P/OCF 4.11
P/B 1.78
P/tB N/A
EV/EBITDA 41.44
EPS(TTM)-0.42
EYN/A
EPS(NY)0.02
Fwd EY1.31%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.37
OCFY24.31%
SpS2.28
BVpS0.87
TBVpS-1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.66%
ROE -42.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.63%
FCFM N/A
ROA(3y)-1.48%
ROA(5y)1.53%
ROE(3y)-19.24%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-7.14%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Debt/EBITDA 15.95
Cap/Depr 163.57%
Cap/Sales 29.99%
Interest Coverage N/A
Cash Conversion 527.09%
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 0.26
F-Score5
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)25.66%
Cap/Sales(5y)24.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44%
EPS Next Y30.2%
EPS Next 2Y42.87%
EPS Next 3Y34.84%
EPS Next 5YN/A
Revenue 1Y (TTM)5.33%
Revenue growth 3Y13.43%
Revenue growth 5Y13.47%
Sales Q2Q%3.22%
Revenue Next Year18.71%
Revenue Next 2Y14.6%
Revenue Next 3Y13.1%
Revenue Next 5YN/A
EBIT growth 1Y-131.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2577.72%
EBIT Next 3Y257.58%
EBIT Next 5YN/A
FCF growth 1Y-201.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.01%
OCF growth 3Y-24.68%
OCF growth 5Y-0.09%